Hong presented data from the SURPASS clinical trial at the 2022 European Society for Medical Oncology (ESMO) Congress.
David S. Hong, MD
Advertisement
Articles by David S. Hong, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Decisions to Look For in 1H 2026
2
FDA Activity Recap: December 2025 Features Multiple Approvals, RMAT Designation, and More
3
Around the Helix: Cell and Gene Therapy Company Updates – January 7, 2026
4
Ultragenyx Finishes Rolling Submission of BLA for Glycogen Storage Disease Gene Therapy DTX401
5